About this trial
The investigator aims to prospectively enroll patients who were referred for transthorcic echocardiography (TTE) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent TTE according to established guidelines and local institutional protocols. This study will determine if TTE-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.
Eligibility criteria
Qualifiers
symptomatic patients with SCP suspected of obstructive CAD.
referred for TTE for the assessment of SCP.
≥18 years of age.
signed informed consent.
Disqualifiers
acute coronary syndromes
previous CAD or coronary revascularization
nonsinus rhythm
cardiomyopathy, valvular disease, congenital heart disease or left cardiac insufficiency because of other reasons
Trial design
Treatments tested in this trial
- TTE